Edwards Lifesciences Chairman Michael Mussallem to Retire, Nicholas Valeriani to Succeed

Edwards Lifesciences Corp

Michael A. Mussallem will retire as Non-Executive Chairman and director effective May 7, 2024, the date of the annual meeting.
Nicholas J. Valeriani, an independent director, is expected to be appointed as Chairman of the Board.
Martha H. Marsh will not stand for re-election due to reaching retirement age under company guidelines.
The changes were announced on March 26, 2024, in an 8-K filing by Edwards Lifesciences (NYSE: EW).

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Michael A. Mussallem

Non-Executive Chairman

EW · Edwards Lifesciences Corp

Effective: 2024-05-07
Successor: Nicholas J. Valeriani
Filed: March 26, 2024, 7:59 PM ET

Michael A. Mussallem informed the Board of Directors (the Board) of his decision to retire as Non-Executive Chairman and a director of the Board which will be effective in conjunction with the Company’s annual meeting of stockholders on May 7, 2024

Departed

Martha H. Marsh

director

EW · Edwards Lifesciences Corp

Effective: 2024-05-07
Filed: March 26, 2024, 7:59 PM ET

Martha H. Marsh has reached the retirement age set forth in the Company’s Corporate Governance Guidelines and will therefore not be nominated to stand for election to the Board at the 2024 Annual Meeting.

Appointed

Nicholas J. Valeriani

Chairman of the Board

EW · Edwards Lifesciences Corp

Effective: 2024-05-07
Filed: March 26, 2024, 7:59 PM ET

The Company expects to appoint Nicholas J. Valeriani, an independent director, to succeed Mr. Mussallem as Chairman of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Michael A. Mussallem departed as Non-Executive Chairman at Edwards Lifesciences Corp.

Action: retire
Role: Non-Executive Chairman

Exact text from the filing

Michael A. Mussallem informed the Board of Directors (the Board) of his decision to retire as Non-Executive Chairman and a director of the Board which will be effective in conjunction with the Company’s annual meeting of stockholders on May 7, 2024

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Martha H. Marsh departed as director at Edwards Lifesciences Corp.

Action: will not stand for re-election
Role: director

Exact text from the filing

Martha H. Marsh has reached the retirement age set forth in the Company’s Corporate Governance Guidelines and will therefore not be nominated to stand for election to the Board at the 2024 Annual Meeting.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.9

Nicholas J. Valeriani was appointed as Chairman of the Board at Edwards Lifesciences Corp.

Action: appointed
Role: Chairman of the Board

Exact text from the filing

The Company expects to appoint Nicholas J. Valeriani, an independent director, to succeed Mr. Mussallem as Chairman of the Board.

View on SEC.gov

Edwards Lifesciences Corp filing history →

Source: SEC EDGAR

accession 0001099800-24-000031

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.